Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PARGESA HOLDING SA-BR. We currently have 2 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
PARGESA HOLDING SA-BR
PARGESA HOLDING SA-BR
Less downwards pressure to be expected on the share price
18 Jul 16
During 2015, the euro’s depreciation against the Swiss franc was not the only factor impacting the stock price downwards. As we noted (see our Latest dated 07/08/2015), one of the historical key partners of Pargesa, BNP Paribas, issued exchangeable bonds for Pargesa Holding SA bearer shares. Issued respectively in 2012 and 2013 with an interest rate of 0.25% and admitted to trading on the Euro MTF market in Luxemburg, these bonds were due to mature respectively in 2015 and 2016. Last year, the exchanges led, in all likelihood, to the subscribers selling the received shares in exchange on the market. At 31/12/2014, BNP Paribas still held 11.15% of Pargesa. We have estimated that the bonds could enable BNP Paribas to divest 9% globally. The bank’s position was 6.1% at the end of 2015 (and 3.3% of voting rights). 7% of Pargesa’s capital was consequently sold during the year. Some outstanding bonds may not yet have been exchanged or reimbursed and could lead to further sales of Pargesa shares during 2016. Pargesa noted in its 2015 Annual Report that 2.6% of the voting rights were “__conferred on exchange rights__”. This means that these exchange rights relate primarily to bonds issued in March 2013 by BNP Paribas, maturing in 2016 and exchangeable for Pargesa Holding SA bearer shares. We do not have any information on the situation to date. But the impact might not be as great as in 2015.
Not so graceful last steps to BNP exit
07 Aug 15
The H1 15 consolidated net income amounted to CHF399m (compared with CHF378m in H1 14), including the following items: 1) Pargesa’s share of the partial reversal of the impairment previously recorded by the subsidiary GBL on its holding in Lafarge (CHF221m), 2) Pargesa’s share of the capital gain generated from GBL’s sale of 0.1% of Total (CHF34m), 3) the net gain resulting from the delivery by GBL of Suez Environnement shares to bondholders who exercised their exchange rights early (CHF14m), and 4) the impact of the euro’s depreciation against the Swiss franc since the beginning of the year (an average €/CHF exchange rate of 1.06 in H1 15 compared with 1.22 in H1 14, i.e. a yoy decline of 13.6%), since most income derives from GBL’s contribution which is denominated in euros. Pargesa’s accounts recorded and will record over the year 2015 the transactions carried out by GBL (for more details, see our Latest dated 05/08/2015 on GBL): • The deconsolidation as associate of Lafarge in the group’s accounts, as a consequence of the success of the tender of the Lafarge shares to the public exchange offer launched by Holcim for the purpose of building in July 2015 the merged group LafargeHolcim, in which GBL would hold 9.43% of the share capital; • the dilution of GBL’s shareholding from 56.5% at 31/12/2014 to 53.2% in Imerys share capital, the acquisition by Imerys of the Greek group S&B being partly paid in shares; • the forward sales concluded by GBL on 10.3m shares of Total (0.4% of the share capital) at an average spot price of €48.17 per share, leading to a capital gain of about CHF130m Pargesa’s share; • the further implementation of GBL’s diversification strategy through the development of “Incubator”-type investments, with the stakes acquired in Umicore (13.1%), Ontex (7.4%) and now Adidas (about 3%); • within GBL’s “Financial Pillar”, Sienna Capital and Ergon Capital Partners funds continued to invest in a certain number of companies and disposed of their stakes in other companies, generating capital gains. An amount of CHF12m will be recorded by Pargesa in Q3 15. On the financial side, Pargesa Holding SA issued a CHF150m Swiss domestic bond in order to increase its financial resources and partially fund the redemption of its 2.5% bond of CHF150m maturing in November 2016. Issued in March 2015, the new bond pays an annual coupon of 0.875%, is redeemable in April 2024 and significantly increased Pargesa’s average debt maturity. Concerning the company's organisation, the Vice Chairman of the Board of Directors and Executive Director Albert Frère did not seek another term as Director (see our Latest dated 03/02/2015) and his son Gérald Frère replaced him as Executive Director, following the Annual General Meeting held in May 2015.
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.